dr. levine on combos with parp inhibitors in ovarian cancer
Published 7 years ago • 104 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
6:25
combinations with parp inhibitors for ovarian cancer
-
0:52
dr. levine on the parp inhibitor landscape for ovarian cancer
-
0:56
dr. crane on combinations with parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
0:48
dr. crane on the impact of parp inhibitors in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
1:11
dr. backes discusses parp inhibitor combinations in ovarian cancer
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer
-
0:51
dr. hays on potential for parp inhibitor combinations in ovarian cancer
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
2:22
dr. konecny on the value of parp inhibitors in ovarian cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer